MENU
+Compare
EVGN
Stock ticker: NASDAQ
AS OF
May 22, 04:59 PM (EDT)
Price
$1.19
Change
+$0.01 (+0.85%)
Capitalization
7.92M

EVGN Evogene Ltd. Forecast, Technical & Fundamental Analysis

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications... Show more

Industry: #Biotechnology
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EVGN with price predictions
May 21, 2025

EVGN in upward trend: 10-day moving average moved above 50-day moving average on May 21, 2025

The 10-day moving average for EVGN crossed bullishly above the 50-day moving average on May 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 13, 2025. You may want to consider a long position or call options on EVGN as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EVGN just turned positive on April 21, 2025. Looking at past instances where EVGN's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EVGN advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 130 cases where EVGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for EVGN moved out of overbought territory on May 20, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where EVGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

EVGN moved below its 50-day moving average on May 21, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EVGN broke above its upper Bollinger Band on May 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.834) is normal, around the industry mean (16.453). P/E Ratio (0.304) is within average values for comparable stocks, (59.882). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.200). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.794) is also within normal values, averaging (281.707).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EVGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVGN is expected to report earnings to rise 131.58% to -87 cents per share on August 06

Evogene Ltd. EVGN Stock Earnings Reports
Q2'25
Est.
$-0.88
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.66
Q3'24
Missed
by $0.30
Q2'24
Beat
by $0.19
The last earnings report on May 21 showed earnings per share of -37 cents, beating the estimate of -73 cents. With 10.53K shares outstanding, the current market capitalization sits at 7.92M.
A.I. Advisor
published General Information

General Information

a developer of plant traits for the agriculture and biofuel industries

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
13 Gad Feinstein Street
Phone
+972 89311900
Employees
142
Web
https://www.evogene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQB0.900.07
+8.76%
AquaBounty Technologies
SACH0.90-0.03
-2.86%
Sachem Capital Corp
CNO37.78-1.45
-3.70%
CNO Financial Group
PTLO11.51-0.55
-4.52%
Portillo's
ALB56.44-2.88
-4.86%
Albemarle Corp

EVGN and Stocks

Correlation & Price change

A.I.dvisor tells us that EVGN and AXON have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVGN and AXON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
-6.69%
AXON - EVGN
30%
Poorly correlated
-0.99%
FATE - EVGN
29%
Poorly correlated
-6.40%
ARRY - EVGN
28%
Poorly correlated
-7.30%
RARE - EVGN
27%
Poorly correlated
-5.19%
FBIOP - EVGN
26%
Poorly correlated
-2.28%
More